Copyright for articles published in this journal is retained by the journal.
Author Biographies
H Nafil
Service d’Hématologie, Chu Mohamed VI, Université Cadi Ayyad, Marrakech, Maroc
I Tazi
Service d’Hématologie, Chu Mohamed VI, Université Cadi Ayyad, Marrakech, Maroc
L Mahmal
Service d’Hématologie, Chu Mohamed VI, Université Cadi Ayyad, Marrakech, Maroc
Main Article Content
Prostate cancer and chronic lymphocytic leukemia
H Nafil
I Tazi
L Mahmal
Abstract
The association between prostate cancer and chronic lymphocytic leukemia (CLL) is rare.We report a case of 69 year old man who presented a CLL, classified as Binet stage C, treated with FCR protocol. After six cycles of chemotherapy, itwas in complete remission. Eighteen months after the end of treatment, the patient presented with dysuria and back pain. Digital rectal examination revealed an indurated prostate. The PSA was elevated to 1103 ng/ml. Prostate biopsy with histopathologic study showed poorly differentiated prostate adenocarcinoma (Gleason score: 8). Staging workup revealed bone metastases. Adjuvant radiotherapy and pulpectomy associated with bisphosphonates and analgesics was proposed. The association between CLL and prostate cancer appears too frequent to be accidental.
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.